Our study reveals a novel role of LEC-S1pr1 in the regulation of post-MI cardiac remodeling and functions, providing a potential therapy by modulation of LEC-S1pr1 to resolve cardiac inflammation and to improve cardiac functions after myocardial infarction. The gene discussed is CCL16; the disease is myocardial infarction.